Placental pathologic features of preterm preeclampsia

doi:10.1016/0002-9378(95)91333-5

American Journal of Obstetrics and Gynecology

Volume 173, Issue 4, October 1995, Pages 1097-1105

https://doi.org/10.1016/0002-9378(95)91333-5 Get rights and content

Abstract

OBJECTIVE: Our purpose was to compare the incidence and interrelationships of uteroplacental vasculopathy and chronic inflammatory and placental vasoocclusive lesions in preeclampsia and spontaneous delivery before 32 weeks' gestation.

STUDY DESIGN: Review of singleton live-born nonanomalous infants born at 22 to 32 weeks' gestation identified 76 cases of preeclampsia and 353 cases of spontaneous prematurity (spontaneous premature membrane rupture [n = 192], preterm labor, intact membranes [n = 161]). Histologic lesions were considered as belonging to one of five major pathophysiologic groups: (1) uteroplacental vascular lesions and related villous lesions, (2) chronic inflammatory lesions, (3) coagulation-related lesions, (4) acute inflammatory lesions, and (5) unclassified lesions. Contingency table analyses considered p < 0.05 significant. Factor analysis extracted combinations of related variables.

RESULTS: More frequent in preeclampsia versus spontaneous prematurity were chronic uteroplacental vasculitis (29% vs 20%, p < 0.05), chronic villitis (20% vs 3%, p < 0.001), avascular villi (39% vs 16%, p < 0.001), and “hemorrhagic endovasculitis” (9% vs 2.5%, p < 0.03). In the preeclampsia cases factor analysis extracted 13 categories of related lesions. Four categories contained uteroplacental vascular lesions. Five categories included lesions related to chronic inflammation, and eight included lesions related to coagulation. Four categories loaded lesions from one major pathophysiologic group only. Three categories loaded lesions from all three pathophysiologic groups. Unclassified lesions loaded into two factor categories that were unrelated to the other lesions.

CONCLUSIONS: Chronic inflammatory and placental vasoocclusive lesions are more common in preterm preeclampsia than in spontaneous prematurity. Immunopathologic processes and coagulation may be involved in the pathophysiologic mechanisms of preterm preeclampsia independent of uteroplacental vascular pathologic features.

References (37)

F Arias et al.
Maternal placental vasculopathy and infection: two distint subgroups among patients with preterm labor and preterm ruptured membranes
Am J Obstet Gynecol
(1993)
CM Salafia et al.
Histologic evidence of old intrauterine bleeding is more frequent in prematurity
Am J Obstet Gynecol
(1995)
CM Salafia et al.
Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features
Am J Obstet Gynecol
(1995)
WB Robertson et al.
The placental bed biopsy: review from three European centers
Am J Obstet Gynecol
(1986)
TY Khong et al.
Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion
Am J Obstet Gynecol
(1987)
NG Stevens et al.
Placental hemorrhagic endovasculitis: risk factors and impact on pregnancy outcome
Int J Gynecol Obstet
(1984)
RW Redline et al.
Clinical and pathological aspects of recurrent placental villitis
Hum Pathol
(1985)
TY Khong et al.
Immunohistologic demonstration of endothelial disruption in acute atherosis in pre-eclampsia
Eur J Obstet Gynecol Reprod Biol
(1993)
DW Branch
Antiphospholipid antibodies and pregnancy: maternal implications
Semin Perinatol
(1990)
DA Triplett
Antiphospholipid antibodies: proposed mechanisms of action
Am J Reprod Immunol
(1992)

MD Lockshin

Pregnancy associated with systemic lupus erythematosus

Semin Perinatol

(1990)

P Emrich et al.

Beitrag zur morphologic der myometrialen und dezidualen arterien bei normalen schwangerschaften, EPH-gestosen und müterlichen diabetes mellitus

Pathol Microbiol

(1975)

CA Labarrere et al.

Placental lesions in maternal autoimmune diseases

Am J Reprod Immunol

(1986)

TY Khong et al.

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

Br J Obstet Gynaecol

(1986)

E Wolfe et al.

Do survival and morbidity of the very-low-birth-weight infant vary according to primary pregnancy complications resulting in preterm delivery?

Am J Obstet Gynecol

(1993)

CM Salafia et al.

The very low birth weight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth

Am J Perinatol

(1995)

CM Salafia et al.

Maternal, placental and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born at <32 weeks gestation

Am J Perinatol

(1995)

CM Salafia

Placental pathology in perinatal diagnosis

Cited by (248)

Histopathologic and Transcriptomic Profiling Identifies Novel Trophoblast Defects in Patients With Preeclampsia and Maternal Vascular Malperfusion
2023, Modern Pathology
Preeclampsia (PE) is a heterogeneous disease for which the current clinical classification system is based on the presence or absence of specific clinical features. PE-associated placentas also show heterogeneous findings on pathologic examination, suggesting that further subclassification is possible. We combined clinical, pathologic, immunohistochemical, and transcriptomic profiling of placentas to develop integrated signatures for multiple subclasses of PE. In total, 303 PE and 1388 nonhypertensive control placentas were included. We found that maternal vascular malperfusion (MVM) in the placenta was associated with preterm PE with severe features and with small-for-gestational-age neonates. Interestingly, PE placentas with either MVM or no histologic pattern of injury showed a linear decrease in proliferative (p63⁺) cytotrophoblast per villous area with increasing gestational age, similar to placentas obtained from the nonhypertensive patient cohort; however, PE placentas with fetal vascular malperfusion or villitis of unknown etiology lost this phenotype. This is mainly because of cases of fetal vascular malperfusion in placentas of patients with preterm PE and villitis of unknown etiology in placentas of patients with term PE, which are associated with a decrease or increase, respectively, in the cytotrophoblast per villous area. Finally, a transcriptomic analysis identified pathways associated with hypoxia, inflammation, and reduced cell proliferation in PE-MVM placentas and further subclassified this group into extravillous trophoblast-high and extravillous trophoblast-low PE, confirmed using an immunohistochemical analysis of trophoblast lineage-specific markers. Our findings suggest that within specific histopathologic patterns of placental injury, PE can be subclassified based on specific cellular and molecular defects, allowing the identification of pathways that may be targeted for diagnostic and therapeutic purposes.
Placental pathology
2022, Reproductive and Developmental Toxicology
Chronic Villitis of unknown etiology (VUE): Obstetrical features, outcome and treatment
2021, Journal of Reproductive Immunology
Villitis of unknown etiology (VUE) is characterized by lympho-histiocytic infiltrates, which are predominant within the villous stroma. VUE can be of low grade i.e. affecting less than 10 contiguous villi or high grade with either patchy or diffuse subgroups (the later concerning more than 30 % of distal villi). Several other placental lesions could be associated with VUE, in particular in diffuse subgroups, such as diffuse perivillous fibrin deposition and chronic intervillositis. One of the most characteristic features of VUE is the late onset of fetal growth restriction after 32 weeks of gestation, and earlier detection of villitis should first raise an infectious origin. High grade VUE has been associated with fetal growth restriction, prematurity, fetal deaths, recurrent pregnancy loss, central nervous system injury and is characterized by relatively high risk of recurrence (25–50 %). Prospective and well-designed studies are necessary to determine the real prevalence of these adverse pregnancy events associated with VUE. Data about the management of VUE are extremely scarce and thus no recommendation based on the literature review could be actually done.
Associations of thrombocytopenia, transaminase elevations, and transfusion with laboratory coagulation tests in women with preeclampsia: a cross-sectional study
2021, International Journal of Obstetric Anesthesia
Women with preeclampsia may develop coagulopathy, predisposing to bleeding complications. Although guidelines and prior studies conflict, we hypothesized that in preeclampsia, abnormal coagulation test results are more common in women with thrombocytopenia or transaminase elevations and increase the transfusion risk. Our objectives were to investigate: 1. patterns of coagulation testing; 2. relationships between platelet count, transaminase level, and the risk of abnormal coagulation tests; 3. risk of bleeding complications; and 4. characteristics of patients with markedly abnormal coagulation parameters.
We conducted a cross-sectional study of deliveries of women with preeclampsia who had undergone activated partial thromboplastin time (aPTT) or international normalized ratio (INR) testing at one of two hospitals between 1994 and 2018.
Of 10 699 women with preeclampsia, 3359 (32.7%) had coagulation testing performed and aPTT or INR elevations were present in 124 (3.7 %). Coagulation abnormalities were more common in women with thrombocytopenia or transaminase elevations (n=82) compared with those without (n=42) (6.7%, 95% CI 5.5 to 8.2 vs 1.8%, 95% CI 1.3 to 2.5). Transfusion was more common among women with abnormal coagulation parameters (n=124) compared with those without (n=39) (33.1 vs 7.0%, P <0.001). Among 26 patients with an aPTT ≥40 s or an INR ≥1.4, six required transfusion (all had placental abruption and disseminated intravascular coagulopathy).
Coagulation testing was inconsistently performed in this cohort. Platelet counts and transaminase levels inadequately detected abnormal coagulation test results. Abnormal coagulation test results were associated with a markedly higher risk for red blood cell transfusion.
Association between serum beta-human chorionic gonadotropin and inflammation, oxidative stress in pregnancy-induced hypertension
2021, Microvascular Research
The aberrant increase of circulating beta-human chorionic gonadotropin (β-HCG) at early stages of pregnancy can be used to predict gestational hypertension. However, the association of β-HCG and inflammation, oxidative stress in pregnancy-caused hypertensive disorder on perinatal stage remains unclear. A case-controlled study was performed, with 133 adult pregnant women participated in their perinatal stage. Participants in this research included 45 with mild preeclampsia, 40 with severe preeclampsia and 48 without hypertension. Higher circulating β-HCG level was correlated with severer pregnancy-induced hypertension. Independent contribution of inflammatory factors including interleukin-6, tumor necrosis factor-α and interferon-γ and oxidative stress factors including thiobarbituric acid reactive substance and total antioxidant capacity to severe pregnancy-induced hypertension was significant (P < 0.001). The correlation of circulating β-HCG levels with inflammatory and oxidative stress markers in patients with pregnancy-induced hypertension in perinatal stage was statistically significant.
Region-specific changes in the mRNA and protein expression of LCPUFA biosynthesis enzymes and transporters in the placentae of women with preeclampsia
2020, Placenta
The biosynthesis and transport of long chain polyunsaturated fatty acids (LCPUFA) require the activity of fatty acid desaturase (FADS) enzymes, fatty acid transport proteins (FATP) and fatty acid binding proteins (FABP). In a previous study we have demonstrated region-specific changes in the LCPUFA levels in preeclampsia (PE) as compared to the normotensive control (NC) placentae.
To understand the region-specific changes in the mRNA levels and protein expression of biosynthesis enzymes and transporters of LCPUFA in PE and NC placentae.
In this cross-sectional study, 20 NC women and 44 women with PE (23 term (TPE) and 21 preterm PE (PTPE)) were recruited. The samples were collected from four regions of the placentae considering cord insertion as the center (CM, central maternal/basal; CF, central fetal/chorionic; PM, peripheral maternal/basal and PF, peripheral fetal/chorionic). The mRNA levels were estimated using qRT-PCR. Statistical analysis was done using both post hoc least significant difference (LSD) test and Benjamini Hochberg correction in the analysis of covariance. Preliminarily, localization and expression of proteins were studied by immunohistochemistry (n = 3/group).
The mRNA levels of FADS1, FADS2 and FATP1 were lower in the central regions (CM and CF) of the PE placentae (both TPE and PTPE) as compared to NC. These differences in the mRNA levels were observed by the LSD test and were not significant after the Benjamini Hochberg correction. Preliminary findings of IHC indicate that the protein expression of FADS1 and FATP4 was higher in the basal regions (CM and PM) of the PE placentae as compared to NC. FADS1, FADS2 and FATP4 proteins were localized in the syncytiotrophoblasts, cytotrophoblasts, mesenchymal cells, endothelial cells of the fetal capillaries and extravillous trophoblasts of the placenta.
FADS enzymes are detected in the placentae of Indian women. In PE placentae, there are region-specific alterations in the mRNA and protein levels of LCPUFA biosynthesis enzymes (FADS1 and FADS2) and transporters (FATP1, FATP4 and FABP3) as compared to term NC. These changes were more pronounced toward the basal side and region around the cord insertion.

View all citing articles on Scopus

^☆: Supported by National Institutes of Health contract No. N01-HD 3-3198 (C.M.S., J.C.P.) and in part by an Interagency Personnel Agreement of the National Institutes of Health with the University of Connecticut (C.M.S.).

^☆☆: Presented in part at the Fifteenth Annual Meeting of the Society of Perinatal Obstetricians, Atlanta, Georgia, January 23–28, 1995.

View full text

Placental pathologic features of preterm preeclampsia☆,☆☆

Abstract

Am J Obstet Gynecol

Am J Obstet Gynecol

Am J Obstet Gynecol

Am J Obstet Gynecol

Am J Obstet Gynecol

Int J Gynecol Obstet

Hum Pathol

Eur J Obstet Gynecol Reprod Biol

Antiphospholipid antibodies and pregnancy: maternal implications

Semin Perinatol

Antiphospholipid antibodies: proposed mechanisms of action

Am J Reprod Immunol

Pregnancy associated with systemic lupus erythematosus

Semin Perinatol

Beitrag zur morphologic der myometrialen und dezidualen arterien bei normalen schwangerschaften, EPH-gestosen und müterlichen diabetes mellitus

Pathol Microbiol

Placental lesions in maternal autoimmune diseases

Am J Reprod Immunol

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

Br J Obstet Gynaecol

Do survival and morbidity of the very-low-birth-weight infant vary according to primary pregnancy complications resulting in preterm delivery?

Am J Obstet Gynecol

The very low birth weight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth

Am J Perinatol

Maternal, placental and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born at <32 weeks gestation

Am J Perinatol

Placental pathology in perinatal diagnosis